113 related articles for article (PubMed ID: 31949800)
1. P1-HNF4α expression negatively correlates with HER2 levels and is associated with good prognosis in gastric adenocarcinoma.
Zhang Z; Hu J; Chu M; Peng X; Zhang Y; Yi W; Ma X
Int J Clin Exp Pathol; 2018; 11(8):4093-4100. PubMed ID: 31949800
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
4. Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study.
Wei Z; Huang L; Zhang X; Xu A
BMC Gastroenterol; 2020 Oct; 20(1):343. PubMed ID: 33059614
[TBL] [Abstract][Full Text] [Related]
5. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.
Rokutan-Kurata M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Koyama M; Shigeto S; Fujimoto M; Zhang M; Morita S; Date H; Haga H
Clin Lung Cancer; 2017 Jul; 18(4):e273-e281. PubMed ID: 28065467
[TBL] [Abstract][Full Text] [Related]
6. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
[TBL] [Abstract][Full Text] [Related]
8. Association between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinoma.
Chen L; Yang X; Yang X; Fan K; Xiao P; Zhang J; Wang X
Exp Ther Med; 2016 Jul; 12(1):238-244. PubMed ID: 27347043
[TBL] [Abstract][Full Text] [Related]
9. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS
Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783
[TBL] [Abstract][Full Text] [Related]
11. Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Adenocarcinoma.
Halder S; Mallick D; Mondal P; Roy DS; Halder A; Chakrabarti S
Indian J Med Paediatr Oncol; 2017; 38(2):153-157. PubMed ID: 28900323
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
13. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
15. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
Sugano M; Nagasaka T; Sasaki E; Murakami Y; Hosoda W; Hida T; Mitsudomi T; Yatabe Y
Am J Surg Pathol; 2013 Feb; 37(2):211-8. PubMed ID: 23108025
[TBL] [Abstract][Full Text] [Related]
16. Assessment of EGFR and ERBB2 (HER2) in Gastric and Gastroesophageal Carcinomas: EGFR Amplification is Associated With a Worse Prognosis in Early Stage and Well to Moderately Differentiated Carcinoma.
Liao JB; Lee HP; Fu HT; Lee HS
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):374-382. PubMed ID: 27753660
[TBL] [Abstract][Full Text] [Related]
17. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
Liu JN; Wang HB; Zhou CC; Hu SY
Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma.
Cai SH; Lu SX; Liu LL; Zhang CZ; Yun JP
Therap Adv Gastroenterol; 2017 Oct; 10(10):761-771. PubMed ID: 29051787
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.
Polkowski W; van Sandick JW; Offerhaus GJ; ten Kate FJ; Mulder J; Obertop H; van Lanschot JJ
Ann Surg Oncol; 1999; 6(3):290-7. PubMed ID: 10340889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
